Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

115 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Postoperative wound infections in elective colorectal surgery].
Flatmark K, Nilsen BH. Flatmark K, et al. Tidsskr Nor Laegeforen. 2000 Sep 30;120(23):2761-3. Tidsskr Nor Laegeforen. 2000. PMID: 11107920 Norwegian.
Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients.
Flatmark K, Bjørnland K, Johannessen HO, Hegstad E, Rosales R, Hårklau L, Solhaug JH, Faye RS, Søreide O, Fodstad Ø; Study Group for Micrometastases in BM in Colorectal Cancer. Flatmark K, et al. Clin Cancer Res. 2002 Feb;8(2):444-9. Clin Cancer Res. 2002. PMID: 11839662
Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer.
Bjørnland K, Flatmark K, Mala T, Mathisen O, Bakka A, Aasen AO, Bergan A, Søreide O, Fodstad O. Bjørnland K, et al. J Surg Oncol. 2003 Apr;82(4):224-7. doi: 10.1002/jso.10223. J Surg Oncol. 2003. PMID: 12672004
Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer.
Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, Bjørnland K, Fodstad Ø, Maelandsmo GM. Flatmark K, et al. J Pathol. 2003 Aug;200(5):589-95. doi: 10.1002/path.1381. J Pathol. 2003. PMID: 12898594 Clinical Trial.
Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum.
Flatmark K, Maelandsmo GM, Mikalsen SO, Nustad K, Varaas T, Rasmussen H, Meling GI, Fodstad Ø, Paus E. Flatmark K, et al. Tumour Biol. 2004 Jan-Apr;25(1-2):31-40. doi: 10.1159/000077721. Tumour Biol. 2004. PMID: 15192310
Matrix metalloproteinases participate in osteosarcoma invasion.
Bjørnland K, Flatmark K, Pettersen S, Aaasen AO, Fodstad O, Maelandsmo GM. Bjørnland K, et al. J Surg Res. 2005 Aug;127(2):151-6. doi: 10.1016/j.jss.2004.12.016. Epub 2005 Apr 14. J Surg Res. 2005. PMID: 16083752
DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting.
Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y. Ree AH, et al. Anticancer Res. 2006 May-Jun;26(3A):1909-16. Anticancer Res. 2006. PMID: 16827124
Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition.
Flatmark K, Nome RV, Folkvord S, Bratland A, Rasmussen H, Ellefsen MS, Fodstad Ø, Ree AH. Flatmark K, et al. Radiat Oncol. 2006 Aug 3;1:25. doi: 10.1186/1748-717X-1-25. Radiat Oncol. 2006. PMID: 16887021 Free PMC article.
Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice.
Seierstad T, Folkvord S, Røe K, Flatmark K, Skretting A, Olsen DR. Seierstad T, et al. Neoplasia. 2007 May;9(5):392-400. doi: 10.1593/neo.07154. Neoplasia. 2007. PMID: 17534444 Free PMC article.
115 results
Jump to page